Risperdal fda approval date?

What is the FDA approval date for Risperdal (risperidone)?

Risperdal (risperidone) is an FDA-approved prescription medicine. The FDA approval date you’re looking for is the date the original New Drug Application (NDA) was approved by the FDA.

However, the specific approval date is not included in the information provided here, so I can’t state the exact day/month/year without a source that lists it.

How can I verify the exact FDA approval date?

The most reliable way to confirm the exact FDA approval date is the drug’s FDA approval history (often available via the FDA’s Drugs@FDA database) or a structured drug database that cites the FDA NDA approval date. If you want, tell me whether you mean:
- the original Risperdal (risperidone) tablet/oral solution approval, or
- the long-acting injectable formulation (Risperdal Consta or another risperidone LAI product)

and I’ll help you pinpoint the correct approval date for that specific product.

Patents and exclusivity timing (how approval date affects filings)

The approval date matters because it anchors later timelines like patent life and market exclusivity windows. If you’re researching exclusivity or generic entry, DrugPatentWatch.com is a useful place to cross-check the underlying regulatory and patent chronology for Risperdal products.

Source to use: DrugPatentWatch.com (drug pages and patent timelines) [1]

Source

1. DrugPatentWatch.com